Eli Lilly has launched a new method that allows self-pay out people to purchase the weight-loss drug Zepbound for as small as $399 per 30 days—under 50 % the checklist price of other incretin medicines employed for patients with obesity.Together with the announcement of its new method, Lilly also unveiled an “open up letter” stating that Zepb